focus -WSS

focus

author：explore 2025-09-27 10:27:04 - browse：5

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Menendez indictment could see pharma lose a key ally

leisure time

focus

WSS

Food as medicine: Medically tailored meals may get standardized

Sudafed saga points to U.S. issues with evaluating older drugs

Patient advocates debate FDA's accelerated approval process

Will generative AI in health care meet the fate of IBM's Dr. Watson?

FDA's naming rule on biosimilars has undermined competition

explore

focus

leisure time

Medical records are filled with copy

Supreme Court mifepristone arguments center on docs' right to sue

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: mifepristone case, GLP

Affirmative action in medical school literally saved lives

How one patient went off dialysis — and others can too

Medical records are filled with copy

Shingles, which affected Dianne Feinstein, is on the rise

Moonlake's readout produced a cash windfall. Risks remain

Medicaid, Medicare dual

focus

WHO recommends dropping component of many flu vaccines

Data show record exodus of life scientists from academia

Why the world’s most expensive drug might be worth the price

Intercept Pharmaceuticals sells itself for less than $1 billion

Food as medicine: Medically tailored meals may get standardized

Address the ethical violations that led to 'Three Identical Strangers'

explore

Wikipedia

focus

leisure time